Stay updated on Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial
Sign up to get notified when there's something new on the Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial page.

Latest updates to the Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial page
- Check4 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for a completed Phase 1 study comparing subcutaneous and intravenous ARGX-113 in healthy male subjects. It includes the study design, participant eligibility, locations, outcome measure, and record history.SummaryDifference39%

- Check11 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide banner announces an NIH content transition and says “Super Intelligence” may appear in place of “Artificial Intelligence.”SummaryDifference1%

- Check25 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page; the error screen otherwise remains unchanged.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual study record content. This blocks access to core information such as study details, locations, and related materials on this page.SummaryDifference17%

Stay in the know with updates to Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing SC vs IV ARGX-113 in Healthy Males Clinical Trial page.